Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  palladium Pd 103
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-6 of 6 for your search:
Start Over
Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000068851, ACOSOG-Z0070, NCT00023686
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
Phase: Phase III
Type: Health services research, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0232, CDR0000288823, NCI-2009-01091, CTSU, NCT00063882
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068228, U10CA031946, CALGB-99809, NCT00006359
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069248, NCCTG-N0052, N0052, NCT00032006
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0526, CDR0000533887, NCT00450411
Comparison of Two Types of Biopsy in Patients With Breast Lesions
Phase: No phase specified
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-12114, NCI-G00-1808, MCC-IRB-5499, NCT00006031
Start Over